Genetic variation in microRNA-423 and microRNA-137 genes among patients with breast cancer
Keywords:
Breast Cancer , Microrna-423, MIR 137 Gene VNTR, ARMS-PCR, Genetic PolymorphismAbstract
Aim MicroRNAs (miRNAs) are a family of non-coding RNAs that have been suggested as novel markers or therapeutic targets for breast cancer. In current study, we aimed to investigate the prevalence of microRNA-423 rs6505162C/T and the VNTR length of the MIR 137 gene (rs58335419) with regards to breast cancer susceptibility in Iraqi women. Methods: In this study, 190 individuals took part, out of which 110 were breast cancer patients and 80 were healthy controls. The amplification refractory mutation system PCR method (ARMS-PCR) was used to determine the polymorphism in the microRNA-423 (rs6505162) gene. While the VNTR length of the MIR 137 gene (rs58335419) was identified using PCR. The Graph Pad Prism 9 software was used to conduct the statistical analysis. Results: the allele frequency of T in the microRNA-423 rs6505162 was significantly associated with breast cancer (odds ratio [95% confidence interval] 2.333 [1.519-3.600], Risk factor [95% confidence interval]) 1.400 [1.184-1.655], p < 0.0001). On the other hand, all the allele frequencies in the MIR 137 gene (rs58335419) were not found to be associated with breast cancer. Conclusion: Based on the results, the study suggests that microRNA-423 rs6505162C/T could be useful markers for diagnosing breast cancer, whereas the MIR 137 gene (rs58335419) is not useful for diagnosing breast cancer.
References
Michailidou, K., Lindström, S., Dennis, J., Beesley, J., Hui, S., Kar, S., Lemaçon, A., Soucy, P., Glubb, D., Rostamianfar, A., Bolla, M. K., Wang, Q., Tyrer, J., Dicks, E., Lee, A., Wang, Z., Allen, J., Keeman, R., Eilber, U., … Easton, D. F. (2017). Association analysis identifies 65 new breast cancer risk loci. Nature, 551(7678). doi.Org /10.1038/nature24284
H. Mahdi et al., 'Cancer burden among Arab-world females in 2020: Working toward improving outcomes', JCO Glob. Oncol., vol. 8, no. 8, p. e2100415, Mar. 2022. doi.org/10.1200/GO.21.00415
M. M. Y. Al-Hashimi, 'Trends in breast cancer incidence in Iraq during the period 2000-2019', Asian Pac. J. Cancer Prev., vol. 22, no. 12, pp. 3889-3896, Dec. 2021. doi.org/10.31557/APJCP.2021.22.12.3889
A. Smolarz, A. Z. Nowak, and H. Romanowicz, 'Breast cancer-epidemiology, classification, pathogenesis and treatment (review of literature)', Cancers (Basel), vol. 14, no. 10, p. 2569, May 2022. doi.org/10.3390/cancers14102569
M. Kamińska, T. Ciszewski, K. Łopacka-Szatan, P. Miotła, and E. Starosławska, 'Breast cancer risk factors', Prz. Menopauzalny, vol. 14, no. 3, pp. 196-202, Sept. 2015. doi.org/10.5114/pm.2015.54346
W. Majeed et al., 'Breast cancer: major risk factors and recent developments in treatment', Asian Pac. J. Cancer Prev., vol. 15, no. 8, pp. 3353-3358, 2014. doi.org/10.7314/APJCP.2014.15.8.3353
Q.-W. Liu, Y. He, and W. W. Xu, 'Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer', Exp. Mol. Med., vol. 54, no. 3, pp. 216-225, Mar. 2022. doi.org/10.1038/s12276-022-00744-w
M. U. Kaikkonen, M. T. Y. Lam, and C. K. Glass, 'Non-coding RNAs as regulators of gene expression and epigenetics', Cardiovasc. Res., vol. 90, no. 3, pp. 430-440, June 2011. doi.org/10.1093/cvr/cvr097
K. Ranganathan and V. Sivasankar, 'MicroRNAs - Biology and clinical applications', J. Oral Maxillofac. Pathol., vol. 18, no. 2, pp. 229-234, May 2014. doi.org/10.4103/0973-029X.140762
S. F. Fotsing et al., 'The impact of short tandem repeat variation on gene expression', Nat. Genet., vol. 51, no. 11, pp. 1652-1659, Nov. 2019. doi.org/10.1038/s41588-019-0521-9
Kim, Y. D., Lee, J. Y., Oh, K. M., Araki, M., Araki, K., Yamamura, K. I., & Jun, C. D. (2011). NSrp70 is a novel nuclear speckle-related protein that modulates alternative pre-mRNA splicing in vivo. Nucleic Acids Research, 39(10). 10.1093/nar/ gkq1267 doi.org/10.1093/nar/gkq1267
R. A. Smith, D. J. Jedlinski, P. N. Gabrovska, S. R. Weinstein, L. Haupt, and L. R. Griffiths, 'A genetic variant located in miR-423 is associated with reduced breast cancer risk', Cancer Genomics and Proteomics, vol. 9, no. 3, 2012.
J. Yin et al., 'miR-137: a new player in schizophrenia', Int. J. Mol. Sci., vol. 15, no. 2, pp. 3262-3271, Feb. 2014. doi.org/10.3390/ijms15023262
A. Pacheco, R. Berger, R. Freedman, and A. J. Law, 'A VNTR regulates miR-137 expression through novel alternative splicing and contributes to risk for schizophrenia', Sci. Rep., vol. 9, no. 1, p. 11793, Aug. 2019. doi.org/10.1038/s41598-019-48141-0
Q. Chen, X. Chen, M. Zhang, Q. Fan, S. Luo, and X. Cao, 'miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42', Dig. Dis. Sci., vol. 56, no. 7, pp. 2009-2016, July 2011. doi.org/10.1007/s10620-010-1536-3
M. Bakhtiari et al., 'Variable number tandem repeats mediate the expression of proximal genes', Nat. Commun., vol. 12, no. 1, p. 2075, Apr. 2021. doi.org/10.1038/s41467-021-22206-z
M. Rajaei, I. Saadat, S. Omidvari, and M. Saadat, 'Association between polymorphisms at promoters of XRCC5 and XRCC6 genes and risk of breast cancer', Med. Oncol., vol. 31, no. 4, p. 885, Apr. 2014. doi.org/10.1007/s12032-014-0885-8
A. M. Rose et al., 'MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer', Ann. Oncol., vol. 29, no. 5, pp. 1292-1303, May 2018. doi.org/10.1093/annonc/mdy082
K. Otmani, R. Rouas, M. Berehab, and P. Lewalle, 'The regulatory mechanisms of oncomiRs in cancer', Biomed. Pharmacother., vol. 171, no. 116165, p. 116165, Feb. 2024. doi.org/10.1016/j.biopha.2024.116165
T. Dai et al., 'MiR-423 promotes breast cancer invasion by activating NF-κB signaling', Onco. Targets. Ther., vol. 13, pp. 5467-5478, June 2020. doi.org/10.2147/OTT.S236514
H. Zhao et al., 'Genetic analysis and preliminary function study of miR-423 in breast cancer', Tumour Biol., vol. 36, no. 6, pp. 4763-4771, June 2015. doi.org/10.1007/s13277-015-3126-7
S. Morales et al., 'Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population', BMC Genet., vol. 17, no. 1, Dec. 2016. doi.org/10.1186/s12863-016-0415-0
R. Mir, I. A. Al Balawi, and F. M. A. Duhier, 'Involvement of microRNA-423 gene variability in breast cancer progression in Saudi Arabia', Asian Pac. J. Cancer Prev., vol. 19, no. 9, pp. 2581-2589, Sept. 2018.
L. T. Bemis et al., 'MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines', Cancer Res., vol. 68, no. 5, pp. 1362-1368, Mar. 2008. doi.org/10.1158/0008-5472.CAN-07-2912
P. Jafari, S. Baghernia, M. Moghanibashi, and P. Mohamadynejad, 'Significant association of variable number tandem repeat polymorphism rs58335419 in the MIR137 gene with the risk of gastric and colon cancers', Br. J. Biomed. Sci., vol. 79, p. 10095, Feb. 2022. doi.org/10.3389/bjbs.2021.10095
Y. Yang, F. Li, M. N. Saha, J. Abdi, L. Qiu, and H. Chang, 'MiR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma', Clin. Cancer Res., vol. 21, no. 10, pp. 2399-2411, May 2015. doi.org/10.1158/1078-0432.CCR-14-1437
W.-P. Bi, M. Xia, and X.-J. Wang, 'miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4', Oncol. Lett., vol. 15, no. 6, pp. 8744-8748, June 2018.
S. Nuzzo et al., 'Axl-targeted delivery of the oncosuppressor miR-137 in non-small-cell lung cancer', Mol. Ther. Nucleic Acids, vol. 17, pp. 256-263, Sept. 2019. doi.org/10.1016/j.omtn.2019.06.002
L. Wilkinson and T. Gathani, 'Understanding breast cancer as a global health concern', Br. J. Radiol., vol. 95, no. 1130, p. 20211033, Feb. 2022. doi.org/10.1259/bjr.20211033
A. H. El-Ashry, A. M. G. Albeltagy, A. M. Ramez, and S. R. Hendawy, 'Influence of micro-RNA-423 gene variation on risk and characteristics of breast cancer', Asian Pac. J. Cancer Prev., vol. 23, no. 11, pp. 3771-3777, Nov. 2022. doi.org/10.31557/APJCP.2022.23.11.3771
Allam, M. M., Diab, K. A., Khalil, F. O., Khalaf, F. A., Abdel-Samiee, M., Sheble, N., Eljaky, M. A., Zayed, E., Othman, W., Abd-Elkreem, M., & Abdelsameea, E. (2022). The association between micro-RNA gene polymorphisms and the development of hepatocellular carcinoma in Egyptian patients. Archives of Medical Science, 18(1), 62-70. doi.org/10.5114/aoms/100600
A. P. Lewis, C. B. Burge, and D. P. Bartel, 'Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets', Cell, vol. 120, no. 1, pp. 15-20, Jan. 2005. doi.org/10.1016/j.cell.2004.12.035
R. Ke, L. Lv, S. Zhang, F. Zhang, and Y. Jiang, 'Functional mechanism and clinical implications of MicroRNA-423 in human cancers', Cancer Med., vol. 9, no. 23, pp. 9036-9051, Dec. 2020. doi.org/10.1002/cam4.3557
Y. Wang et al., 'A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women', Carcinogenesis, vol. 29, no. 6, pp. 1197-1201, June 2008. doi.org/10.1093/carcin/bgn099
S. Morales et al., 'Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population', BMC Genet., vol. 17, no. 1, Dec. 2016. doi.org/10.1186/s12863-016-0415-0
S. J. Lee et al., 'MicroRNA-137 inhibits cancer progression by targeting Del-1 in triple-negative breast cancer cells', Int. J. Mol. Sci., vol. 20, no. 24, p. 6162, Dec. 2019. doi.org/10.3390/ijms20246162
A. Warburton, G. Breen, D. Rujescu, V. J. Bubb, and J. P. Quinn, 'Characterization of a REST-regulated internal promoter in the schizophrenia genome-wide associated gene MIR137', Schizophr. Bull., vol. 41, no. 3, pp. 698-707, May 2015. doi.org/10.1093/schbul/sbu117
Koron, R. (2018). DNA signatures as a predictor of breast cancer risk Disclaimer.
N. Pourmoshir, G. H. Motalleb, and S. Vallian, 'Hsa-miR-423 rs6505162 is associated with the increased risk of breast cancer in Isfahan central province of Iran', Cell J., vol. 22, no. Suppl 1, pp. 110-116, July 2020.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Nahidah Kzar Madhloom

This work is licensed under a Creative Commons Attribution 4.0 International License.
Article history
- Received: 29 August 2024
- Revised: 11 November 2024
- Accepted: 17 November 2024
- Published: 04 January 2025